{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":614,"total_is_capped":false,"direct_labels_cover":2,"predictions_cover":614,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"0392b00aed86","filters":{"venue":"Journal of Cystic Fibrosis"}},"results":[{"id":"W2792598062","doi":"10.1016/j.jcf.2018.02.006","title":"ECFS best practice guidelines: the 2018 revision","year":2018,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":764,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Medicine; Life expectancy; Best practice; Context (archaeology); Cystic fibrosis; Intensive care medicine; Newborn screening; Quality of life (healthcare); Clinical Practice; Pediatrics; Family medicine; Population; Nursing; Internal medicine; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.1938971681312699,"gpt":0.51386625573354,"spread":0.31996908760227,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006722265,0.0004519675,0.002373136,0.0004656307,0.0002105295,0.0001022719,0.0007798671,0.000449183,0.0003426042],"category_scores_gemma":[0.0524089,0.000226313,0.001009021,0.0007964823,0.0002378424,0.0002738774,0.000210528,0.001952784,0.001274521],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006364535,"about_ca_system_score_gemma":0.004822752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002125714,"about_ca_topic_score_gemma":9.027762e-7,"domain_scores_codex":[0.9928553,0.0008495372,0.003256792,0.0003334991,0.002179756,0.0005251039],"domain_scores_gemma":[0.9859028,0.004497878,0.003010134,0.001030007,0.004943546,0.0006155596],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002890647,0.00009527156,1.945021e-7,0.03152583,0.0002139677,0.0002576581,0.00001878603,1.383027e-7,0.000002653127,0.000008824759,0.1620307,0.805557],"study_design_scores_gemma":[0.0004077262,0.002633723,7.127919e-7,0.09710352,0.002866226,0.005214513,0.0000568574,0.00000448344,0.00000198727,0.00001200071,0.8915427,0.0001556045],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001540724,0.9938058,0.0002901243,0.002993826,0.001004224,0.001011693,0.00002916006,0.00001083475,0.0008528521],"genre_scores_gemma":[3.29991e-7,0.9756774,0.0163496,0.001419532,0.00497942,0.00001211582,0.00000772006,0.00009890303,0.001454928],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8054013,"threshold_uncertainty_score":0.9995031,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975909392","doi":"10.1016/j.jcf.2014.03.010","title":"European Cystic Fibrosis Society Standards of Care: Best Practice guidelines","year":2014,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":592,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Medicine; Life expectancy; Best practice; Cystic fibrosis; Population; Family medicine; Pediatrics; Intensive care medicine; Environmental health; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04295695637302385,"gpt":0.4178732665236108,"spread":0.374916310150587,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005772189,0.001093284,0.00624762,0.0006773614,0.0001992054,0.0001746967,0.001089151,0.0004945424,0.0002113391],"category_scores_gemma":[0.04414203,0.0007938428,0.003701413,0.001181849,0.0005364942,0.0005017892,0.0004034611,0.001873979,0.00009881674],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001315186,"about_ca_system_score_gemma":0.00409718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003462418,"about_ca_topic_score_gemma":0.00000272236,"domain_scores_codex":[0.9872925,0.001395854,0.005358309,0.000715884,0.004322397,0.0009150529],"domain_scores_gemma":[0.9749834,0.005113274,0.005689163,0.001269462,0.01209959,0.0008451014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001265167,0.0004017192,0.000004911857,0.1367564,0.002051735,0.0002659007,0.00035176,0.00006747844,0.0004669085,0.0000274482,0.08363929,0.7747013],"study_design_scores_gemma":[0.001526842,0.005417565,0.000008082269,0.1066484,0.01014427,0.002506097,0.0005369519,0.00003034424,0.00005370561,0.00001713791,0.8725813,0.0005293067],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000112908,0.9854023,0.009389264,0.0003818281,0.0008753308,0.0009912275,0.0009622969,0.0000435295,0.001942917],"genre_scores_gemma":[0.00006640855,0.7861992,0.2109839,0.0001173666,0.001915046,0.00001599414,0.0001022593,0.0002470069,0.0003528853],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.788942,"threshold_uncertainty_score":0.9994512,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2159746250","doi":"10.1016/j.jcf.2008.03.009","title":"Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice","year":2008,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":591,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Abbott Diagnostics; Hospital for Sick Children; Cystic Fibrosis Foundation; AOP Orphan; Genome Canada; Chiesi Farmaceutici","keywords":"Cystic fibrosis; Medicine; Interpretation (philosophy); Clinical Practice; Intensive care medicine; Mutation; Internal medicine; Family medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.08042228377408638,"gpt":0.4260154409714069,"spread":0.3455931571973205,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002530807,0.0004935338,0.003719221,0.001693499,0.00008395337,0.00009969805,0.000302433,0.0003842115,0.00004333774],"category_scores_gemma":[0.06398587,0.0003080092,0.00144438,0.002090914,0.0005577139,0.000319096,0.00009240946,0.001531617,0.00001294897],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003467598,"about_ca_system_score_gemma":0.000912762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006458537,"about_ca_topic_score_gemma":0.0000145758,"domain_scores_codex":[0.9915842,0.00217734,0.003958872,0.0004590256,0.001446696,0.0003738843],"domain_scores_gemma":[0.9497573,0.04431963,0.00388098,0.0005957529,0.001155744,0.000290614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007899604,0.001046941,0.0006621855,0.0135491,0.007156661,0.001192514,0.0006345675,0.0009977802,0.00007082427,0.0001050302,0.003803159,0.9628816],"study_design_scores_gemma":[0.005964985,0.01436115,0.02221567,0.1272029,0.05999444,0.01272336,0.0009283748,0.01366012,0.00004197791,0.0002178799,0.7413921,0.00129707],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005184577,0.9900046,0.002676064,0.0004658516,0.0002805579,0.001153393,0.0001451367,0.00001267258,0.00007717208],"genre_scores_gemma":[0.01232738,0.9387136,0.04847931,0.00009786613,0.0001930315,0.00002461086,0.00005242781,0.00006000986,0.00005177507],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9615846,"threshold_uncertainty_score":0.9999372,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975572445","doi":"10.1016/j.jcf.2015.03.003","title":"Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy","year":2015,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":486,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Cystic Fibrosis Canada; National Institutes of Health; Cystic Fibrosis Foundation","keywords":"Cystic fibrosis; Medicine; Cystic fibrosis transmembrane conductance regulator; Inflammation; Immunology; Neutrophil elastase; Lung; Pathogenesis; Bronchiectasis; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03433526322834295,"gpt":0.3569100860143668,"spread":0.3225748227860238,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001807815,0.0007528933,0.003533035,0.001457222,0.00008610628,0.0001633023,0.0004044948,0.0003835681,0.0001219251],"category_scores_gemma":[0.003151294,0.0005471401,0.0007633367,0.001085542,0.0002716844,0.0004576519,0.0001501697,0.0009289078,0.00002655963],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008044179,"about_ca_system_score_gemma":0.002086499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001160224,"about_ca_topic_score_gemma":0.00000236277,"domain_scores_codex":[0.9941176,0.0006480752,0.002345633,0.0005314028,0.001696487,0.0006608267],"domain_scores_gemma":[0.9945106,0.0015447,0.001536338,0.0006126218,0.000719196,0.001076548],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001401784,0.0001413965,0.0005219403,0.03398411,0.0002924224,0.0004591652,0.00009025088,0.00001800063,0.0002783305,0.00001538397,0.001193655,0.9616036],"study_design_scores_gemma":[0.002583655,0.001036079,0.002543148,0.06589756,0.00216872,0.0009371066,0.00004070782,0.0002438419,0.00001944468,0.0002607349,0.9236851,0.0005839214],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00097232,0.9964069,0.0004905526,0.0001420245,0.0003221786,0.001396814,0.0001915461,0.00002856704,0.00004912302],"genre_scores_gemma":[0.0003681795,0.9877529,0.0104469,0.00001770618,0.0008168345,0.0001416769,0.0001050135,0.0001384208,0.0002123797],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9610196,"threshold_uncertainty_score":0.999698,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1999664569","doi":"10.1016/s1569-1993(11)60014-3","title":"Recommendations for the classification of diseases as CFTR-related disorders","year":2011,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":421,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; St. Michael's Hospital; Mount Sinai Hospital; University of Toronto","funders":"European Commission","keywords":"Medicine; Cystic fibrosis; Intensive care medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04194855652784866,"gpt":0.3329156405862668,"spread":0.2909670840584181,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003617651,0.0001061738,0.0002929207,0.0001741212,0.0001047914,0.000013037,0.000202703,0.00005083652,0.0003841269],"category_scores_gemma":[0.002664143,0.0000663729,0.0002597977,0.0002823608,0.0001973525,0.000177572,0.00002448963,0.0001719005,0.000009834446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006399964,"about_ca_system_score_gemma":0.0002179623,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002935938,"about_ca_topic_score_gemma":0.00000492884,"domain_scores_codex":[0.9985926,0.00006214922,0.0006698156,0.0001079734,0.0003834445,0.0001840037],"domain_scores_gemma":[0.9972026,0.001377915,0.0005456391,0.0002500566,0.0004723241,0.0001515106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02333262,0.004416766,0.04167055,0.002020369,0.003323361,0.00001846554,0.006132934,0.000205767,0.2940792,0.01890898,0.1278434,0.4780475],"study_design_scores_gemma":[0.006252257,0.007066478,0.8384967,0.001360424,0.00224928,0.0002069571,0.003805856,0.003266125,0.008860126,0.03237001,0.09575795,0.0003078006],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6451037,0.02850587,0.2371137,0.06862886,0.004200915,0.006439218,0.0008618482,0.0001655348,0.008980333],"genre_scores_gemma":[0.9699839,0.0003192861,0.02915333,0.00004595679,0.00007949574,0.00002829766,0.0000167621,0.00002076659,0.0003522159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7968262,"threshold_uncertainty_score":0.420592,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2808871427","doi":"10.1016/j.jcf.2018.05.004","title":"CFTR modulator theratyping: Current status, gaps and future directions","year":2018,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":291,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Cystic Fibrosis Canada","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Cystic Fibrosis Foundation","keywords":"Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Medicine; Bioinformatics; Computational biology; Pharmacology; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03308293637950941,"gpt":0.3720190219856786,"spread":0.3389360856061692,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005838377,0.0005530529,0.002523368,0.000731833,0.0001785681,0.0001387669,0.0002473907,0.0002909677,0.0002462897],"category_scores_gemma":[0.0009523677,0.0003644353,0.0008346966,0.0006474126,0.0002666356,0.0002297561,0.0001175281,0.001257156,0.00004612275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004515256,"about_ca_system_score_gemma":0.001238344,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005097429,"about_ca_topic_score_gemma":0.000002051107,"domain_scores_codex":[0.9963716,0.0002630762,0.001392843,0.0004058674,0.0009597936,0.0006068305],"domain_scores_gemma":[0.9962801,0.0006510377,0.001123496,0.0004840404,0.0006883795,0.0007729445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002281741,0.0001389762,0.00001285939,0.02038417,0.0005095752,0.000031949,0.00007932536,2.868015e-7,0.00003000052,0.00002937695,0.008747074,0.9698082],"study_design_scores_gemma":[0.0006166791,0.001288962,0.0002195308,0.03449186,0.002047477,0.001463733,0.00003835062,0.00001008328,0.000005460411,0.0001174083,0.9594154,0.0002850311],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006191304,0.9966438,0.0002740016,0.0001325351,0.001943527,0.0006249537,0.0001476074,0.00002978797,0.0001418895],"genre_scores_gemma":[0.000008917517,0.9794163,0.01482259,0.00001454705,0.005379143,0.00002420296,0.00003565911,0.00009692273,0.0002017799],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9695232,"threshold_uncertainty_score":0.9998807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047752768","doi":"10.1016/j.jcf.2015.03.012","title":"Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis","year":2015,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Wellcome Trust","keywords":"Cystic fibrosis; Pseudomonas aeruginosa; Medicine; Burkholderia; Sputum; Staphylococcus aureus; Disease; Pathogen; Burkholderia cepacia complex; Microbiology; Epidemiology; Intensive care medicine; Immunology; Biology; Bacteria; Tuberculosis; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03330602120436318,"gpt":0.3559676018189863,"spread":0.3226615806146232,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002627244,0.000920528,0.005884815,0.002286903,0.00009649235,0.0001142132,0.0005069372,0.0005924889,0.0004117618],"category_scores_gemma":[0.003772167,0.0007368661,0.001040005,0.001468732,0.0003731477,0.0003904184,0.0003795103,0.0009014796,0.00001452712],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006609358,"about_ca_system_score_gemma":0.001835966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002060422,"about_ca_topic_score_gemma":0.000006214196,"domain_scores_codex":[0.9924349,0.0008202199,0.003435233,0.0006575878,0.001591478,0.001060601],"domain_scores_gemma":[0.9933795,0.001659565,0.002674945,0.0006258888,0.0008609422,0.0007990965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002703153,0.0003142376,0.0001609482,0.04756429,0.0006444372,0.0006892149,0.001064776,0.00001282188,0.023693,0.00001617434,0.0006753161,0.9224616],"study_design_scores_gemma":[0.004771763,0.003267828,0.0004673313,0.09071425,0.004428513,0.002949482,0.0004714268,0.00005580105,0.000351834,0.00007281732,0.8915066,0.0009424255],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0152323,0.9809712,0.0002850494,0.00003557334,0.001427734,0.00114712,0.0008270305,0.0000235211,0.00005044468],"genre_scores_gemma":[0.002727941,0.9664344,0.02817893,0.00001079478,0.002017126,0.00008594986,0.0002254798,0.0002167234,0.0001026473],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9215192,"threshold_uncertainty_score":0.9995083,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3007634464","doi":"10.1016/j.jcf.2020.02.015","title":"Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease","year":2020,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"BC Children's Hospital; Hospital for Sick Children; Medtronic; Boomer Esiason Foundation; Cystic Fibrosis Foundation","keywords":"Cystic fibrosis; Medicine; Lung disease; Intensive care medicine; Foundation (evidence); Lung; Disease; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03379079405361553,"gpt":0.3464018717085754,"spread":0.3126110776549599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008292205,0.0006215837,0.001466971,0.0003755642,0.0003679623,0.0001603665,0.0006658465,0.0001563168,0.0001681919],"category_scores_gemma":[0.01922617,0.0004039588,0.0006716544,0.001053834,0.0005795096,0.0003917989,0.0001647047,0.0005458479,0.00001418967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003264993,"about_ca_system_score_gemma":0.001453447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002893415,"about_ca_topic_score_gemma":0.000007572843,"domain_scores_codex":[0.9940096,0.0002433401,0.002199439,0.0006044257,0.002144756,0.0007984145],"domain_scores_gemma":[0.9863419,0.005502902,0.001724214,0.0007244943,0.004678458,0.001028037],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.1353323,0.00112059,0.04137048,0.03026532,0.005287459,0.0004553842,0.006576314,0.1005758,0.4895096,0.0006927539,0.07027519,0.1185388],"study_design_scores_gemma":[0.08323944,0.06125504,0.2812292,0.04350284,0.03629066,0.00207319,0.02744982,0.1660912,0.08787798,0.002406677,0.2030907,0.005493287],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5763518,0.06967971,0.2964375,0.0430185,0.001518379,0.008883426,0.003655825,0.0002711033,0.0001837942],"genre_scores_gemma":[0.7985912,0.0002144275,0.1995181,0.0005025714,0.0007356365,0.000117859,0.0001269532,0.0001196216,0.0000736502],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4016316,"threshold_uncertainty_score":0.9998412,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3020087243","doi":"10.1016/j.jcf.2020.04.012","title":"A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis","year":2020,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; Cystic Fibrosis Canada","funders":"","keywords":"Cystic fibrosis; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Multinational corporation; Virology; Pandemic; Betacoronavirus; Pathology; Internal medicine; Infectious disease (medical specialty); Disease; Outbreak","retraction":null,"screen_n_in":null,"score":{"opus":0.02026015161167135,"gpt":0.314495709877988,"spread":0.2942355582663167,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006055261,0.0003022911,0.0008598752,0.0005835835,0.000078734,0.00009127754,0.0001841932,0.0001090612,0.0001004076],"category_scores_gemma":[0.005164273,0.000240877,0.000207039,0.001383521,0.00007856319,0.0005024879,0.0000949753,0.0005769614,0.00006551659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004112609,"about_ca_system_score_gemma":0.0005512516,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001797663,"about_ca_topic_score_gemma":0.0001111799,"domain_scores_codex":[0.9964744,0.0001204591,0.001187644,0.0003997133,0.001339059,0.0004786555],"domain_scores_gemma":[0.9973055,0.0005016471,0.0006253171,0.0002773959,0.0008101941,0.0004799117],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01033977,0.0004361548,0.1541133,0.000725142,0.0001526059,0.0015751,0.00121546,0.0007282846,0.8241197,0.00001498003,0.003777864,0.002801645],"study_design_scores_gemma":[0.004014455,0.00576906,0.9269023,0.001635753,0.0002039249,0.004328505,0.0001078223,0.002114514,0.04115348,0.00004233381,0.01337313,0.000354734],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9767854,0.0001495641,0.01699165,0.00504946,0.0001779358,0.0006068929,0.00003300535,0.00004185423,0.0001642608],"genre_scores_gemma":[0.9359084,0.00002320373,0.06278458,0.0006362647,0.0004510464,0.00003808354,0.00002871757,0.00005307582,0.00007656986],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7829663,"threshold_uncertainty_score":0.9822677,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2942831377","doi":"10.1016/j.jcf.2019.03.009","title":"An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2–5 years (KLIMB)","year":2019,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Hospital for Sick Children; Imperial College London; Vertex Pharmaceuticals; BC Children's Hospital; Children's Hospital Colorado; University of Alabama; Children's Mercy Hospital; Virginia Commonwealth University; Royal Brompton and Harefield NHS Foundation Trust; University of Minnesota; Indiana University Health; National Institute for Health and Care Research; Children's Healthcare of Atlanta; University of Alabama at Birmingham; Emory University","keywords":"Ivacaftor; Medicine; Cystic fibrosis; Adverse effect; Gastroenterology; Internal medicine; Pediatrics; Cystic fibrosis transmembrane conductance regulator","retraction":null,"screen_n_in":null,"score":{"opus":0.02764503427184865,"gpt":0.344949404903751,"spread":0.3173043706319023,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004850026,0.0001644987,0.0006158194,0.0002852815,0.00005067612,0.00005678539,0.000142152,0.00004737929,0.00003248669],"category_scores_gemma":[0.0003246727,0.0001188456,0.00002628345,0.0002816776,0.00005244764,0.0004126721,0.00008962778,0.0001801893,0.000003037705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002636762,"about_ca_system_score_gemma":0.0001238648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002541308,"about_ca_topic_score_gemma":0.00005510311,"domain_scores_codex":[0.9981328,0.0001566186,0.0006338453,0.0002455616,0.0006013519,0.0002297826],"domain_scores_gemma":[0.9985333,0.0003237617,0.0005284033,0.0002499642,0.0001921456,0.0001723939],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004657088,0.002398659,0.6686711,0.0001193058,0.0002237409,0.0002804321,0.002369868,0.0005739057,0.3070128,0.000003123542,0.00001411221,0.01367581],"study_design_scores_gemma":[0.01625511,0.03532175,0.9412949,0.001050946,0.0001753948,0.0006056724,0.001886823,0.001084724,0.002176836,0.00002206626,0.000006318375,0.0001194672],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984038,0.0003555558,0.00004961979,0.00002089729,0.00002178473,0.001094574,0.000009163105,0.000006478484,0.00003807859],"genre_scores_gemma":[0.9729478,0.00001728458,0.02688338,0.00001560369,0.00004722571,0.00001134126,0.00001057104,0.00002878375,0.00003802646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.304836,"threshold_uncertainty_score":0.4846382,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1968699566","doi":"10.1016/j.jcf.2012.12.006","title":"Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients","year":2013,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Infections and bacterial resistance","field":"Biochemistry, Genetics and Molecular Biology","cited_by":136,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network; SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Stenotrophomonas maltophilia; Cystic fibrosis; Lung transplantation; Internal medicine; Burkholderia cepacia complex; Hazard ratio; Proportional hazards model; Transplantation; Gastroenterology; Pseudomonas aeruginosa; Burkholderia; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.005271098141721177,"gpt":0.2364052862298257,"spread":0.2311341880881045,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001437239,0.0001309372,0.0001908605,0.00008856655,0.00006444233,0.00005354983,0.00005885486,0.0001184979,0.00007664976],"category_scores_gemma":[0.0001062171,0.0001036364,0.00007449031,0.0001215485,0.00004367901,0.00003464201,0.00001756302,0.0001015271,0.000003156721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008640131,"about_ca_system_score_gemma":0.00008582902,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001712999,"about_ca_topic_score_gemma":0.0001561331,"domain_scores_codex":[0.9990247,0.00007948252,0.000425307,0.0001521682,0.0001452423,0.0001730421],"domain_scores_gemma":[0.9993667,0.00003224736,0.0002356905,0.0001108271,0.0001823585,0.00007219493],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0007006214,0.0001273569,0.2921561,0.0004179428,0.00007324717,0.000007739277,0.00005984847,0.0002649857,0.7022315,0.00000995522,0.0002298066,0.003720935],"study_design_scores_gemma":[0.00118952,0.001144201,0.9798752,0.0001704233,0.00007913155,0.00003856228,0.000006064661,0.000124402,0.01654469,0.00005308586,0.000636344,0.0001383945],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971439,0.0003308611,0.001949159,0.0000212957,0.0003016924,0.0001882604,0.00002442875,0.000003258695,0.00003715505],"genre_scores_gemma":[0.9982086,0.0005996955,0.0007904102,0.00001674206,0.0002596195,0.00001925633,0.00002810878,0.00001299117,0.00006452121],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6877191,"threshold_uncertainty_score":0.4226168,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971512067","doi":"10.1016/j.jcf.2013.12.009","title":"A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis","year":2014,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Boehringer Ingelheim (Canada); McGill University Health Centre; Montreal Children's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Cystic Fibrosis Foundation","keywords":"Cystic fibrosis; Medicine; Placebo; Double blind; Antagonist; Lung disease; Receptor antagonist; Internal medicine; Lung; Randomized controlled trial; Gastroenterology; Receptor; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0121357020093496,"gpt":0.3139832868791729,"spread":0.3018475848698233,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001975292,0.0004067467,0.00264652,0.0004758421,0.0001175513,0.00006336028,0.0002487314,0.0001058397,0.00005418069],"category_scores_gemma":[0.002972927,0.0002159073,0.000628809,0.0003503597,0.0005572108,0.0002415714,0.00002731838,0.00020535,7.721511e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001756818,"about_ca_system_score_gemma":0.0004819042,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001785841,"about_ca_topic_score_gemma":0.00002411017,"domain_scores_codex":[0.9959467,0.0005125844,0.001772187,0.0003627361,0.0009494558,0.0004563371],"domain_scores_gemma":[0.9904948,0.006510342,0.001406981,0.0004850547,0.0005871903,0.0005156363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9830962,0.002732438,0.000860819,0.0004678757,0.001126112,0.000006093272,0.0005232074,0.0003636986,0.007240437,0.00004010857,0.00009159398,0.003451362],"study_design_scores_gemma":[0.948705,0.02594343,0.001118687,0.001322889,0.003125461,0.00004626311,0.000126342,0.01594948,0.003239558,0.00007093953,0.000152162,0.000199773],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816425,0.003517322,0.005422835,0.0004356504,0.0001686583,0.008543974,0.0002446303,0.00001220171,0.00001223245],"genre_scores_gemma":[0.9885941,0.0006771497,0.009571921,0.00001456388,0.0004250553,0.0005284847,0.00006440435,0.0000518628,0.00007252909],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03439124,"threshold_uncertainty_score":0.8804444,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2576180223","doi":"10.1016/j.jcf.2017.01.002","title":"Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher","year":2017,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Clinical trial; Cystic fibrosis; Intensive care medicine; Clinical significance; Observational study; Disease; Relevance (law); Clinical research; Perspective (graphical); Population; Pathology; Internal medicine; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.7326570011584032,"gpt":0.6592416022020957,"spread":0.07341539895630744,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06453266,0.0007664881,0.01347102,0.0007495101,0.0002551548,0.0001657303,0.0009266417,0.0008724561,0.00005678879],"category_scores_gemma":[0.6869249,0.0003942098,0.003232969,0.0004297443,0.003667137,0.0003175222,0.0005466441,0.003376378,0.000008342076],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006591588,"about_ca_system_score_gemma":0.002687327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001131562,"about_ca_topic_score_gemma":0.0000485458,"domain_scores_codex":[0.9745843,0.01214848,0.009952269,0.000952501,0.001410502,0.0009519594],"domain_scores_gemma":[0.5494704,0.437517,0.007851006,0.00142681,0.002893304,0.0008414718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.009502911,0.0005988077,0.001403521,0.02580829,0.005400035,0.0002186142,0.0001291759,0.000006106894,0.000004214234,0.0006582978,0.01642269,0.9398474],"study_design_scores_gemma":[0.006220714,0.01512503,0.01410443,0.09273314,0.01643392,0.0007304563,0.001141919,0.0004199427,0.000001309331,0.006537428,0.8459042,0.0006474542],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00011099,0.9887994,0.004776353,0.001025134,0.0007989486,0.003624057,0.0008398358,0.00001123899,0.00001405],"genre_scores_gemma":[0.0002600663,0.9038223,0.09405824,0.00003931935,0.001300351,0.000209869,0.0000198037,0.00008786108,0.0002021662],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9391999,"threshold_uncertainty_score":0.999851,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2914149338","doi":"10.1016/j.jcf.2019.01.008","title":"Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review","year":2019,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Calgary","funders":"European Cystic Fibrosis Society; Cystic Fibrosis Canada; Cystic Fibrosis Trust; Cystic Fibrosis Foundation","keywords":"Medicine; Cystic fibrosis; Antimicrobial; Pseudomonas aeruginosa; Exacerbation; Intensive care medicine; Internal medicine; Microbiology","retraction":null,"screen_n_in":null,"score":{"opus":0.06721629513473354,"gpt":0.3962616801947952,"spread":0.3290453850600617,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00882122,0.001148314,0.01525772,0.0009660689,0.0001055913,0.0001992179,0.0007415461,0.0006736247,0.00004802961],"category_scores_gemma":[0.06273378,0.0007033538,0.001544105,0.001731344,0.0004352943,0.0003973753,0.0003199794,0.002614317,0.00005406569],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008421237,"about_ca_system_score_gemma":0.002457989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002864466,"about_ca_topic_score_gemma":0.00002014171,"domain_scores_codex":[0.9862354,0.002683675,0.007183929,0.0009390718,0.001953732,0.001004149],"domain_scores_gemma":[0.9725453,0.01805358,0.006471773,0.001161572,0.001168165,0.0005995684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001683171,0.0005976399,0.02055366,0.9657161,0.001746639,0.0002400491,0.00003507354,0.000002524634,0.00001345928,0.000001875833,0.0006721152,0.01025259],"study_design_scores_gemma":[0.002744438,0.003093992,0.009114712,0.9586549,0.01953633,0.002497785,0.00003322907,0.00001777234,6.823626e-7,0.00001565979,0.00364055,0.0006499137],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001703219,0.9917164,0.00008429006,0.0001132779,0.0002967078,0.005707307,0.000305174,0.0000433669,0.00003018775],"genre_scores_gemma":[0.0008688073,0.9755006,0.02274589,0.0001706087,0.0001843924,0.0001032505,0.00007850475,0.0001757546,0.0001721911],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.05391256,"threshold_uncertainty_score":0.9996867,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4307170804","doi":"10.1016/j.jcf.2022.10.003","title":"Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI","year":2022,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Genentech; National Institute of Diabetes and Digestive and Kidney Diseases; Gilead Sciences; Eli Lilly and Company; National Institutes of Health; Chiesi USA; Cystic Fibrosis Foundation","keywords":"Ivacaftor; Cystic fibrosis; Medicine; Internal medicine; Cystic fibrosis transmembrane conductance regulator","retraction":null,"screen_n_in":null,"score":{"opus":0.01408747982273745,"gpt":0.2993915437106129,"spread":0.2853040638878754,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001941854,0.0004157002,0.001548214,0.0009356019,0.000161554,0.00004861657,0.0004308479,0.00007837827,0.0005385593],"category_scores_gemma":[0.005715811,0.0003552951,0.0003913107,0.0007491665,0.0003287888,0.0003478528,0.0003827236,0.001108916,0.000004939692],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005682862,"about_ca_system_score_gemma":0.000838479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009025796,"about_ca_topic_score_gemma":0.000001444256,"domain_scores_codex":[0.9941421,0.0003302402,0.00226543,0.0004826744,0.00205994,0.0007196835],"domain_scores_gemma":[0.9955615,0.001350724,0.001452686,0.000562006,0.0005368773,0.0005362547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008391741,0.001335338,0.728723,0.001529231,0.0002670427,0.005123832,0.0001145221,0.0006000081,0.2482511,0.00008732554,0.003307236,0.002269604],"study_design_scores_gemma":[0.0079778,0.01201466,0.913991,0.002573063,0.0005130351,0.04545932,0.001284001,0.0007620337,0.005533665,0.0008963094,0.008446408,0.0005486811],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952527,0.002352576,0.0008882178,0.0004294802,0.00008318237,0.0006744434,0.0001152685,0.00002951435,0.000174672],"genre_scores_gemma":[0.9158516,0.00003131704,0.08311832,0.00006417066,0.0001775113,0.00008293689,0.00001734892,0.00006562788,0.0005911959],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2427174,"threshold_uncertainty_score":0.9998899,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2765420678","doi":"10.1016/j.jcf.2017.07.014","title":"Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine","year":2017,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Cystic fibrosis; Medicine; Dysbiosis; Inflammation; Gastroenterology; Internal medicine; Disease; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.04421039351465807,"gpt":0.3634665687734924,"spread":0.3192561752588343,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003242672,0.0008098141,0.003747432,0.0008751757,0.0002727407,0.0004892274,0.001129837,0.0004772589,0.0001630574],"category_scores_gemma":[0.01803508,0.0004986656,0.0008488086,0.0006041943,0.0006011908,0.0005997432,0.0003099119,0.001745544,0.00003463382],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005032556,"about_ca_system_score_gemma":0.001288744,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005422469,"about_ca_topic_score_gemma":0.00002626654,"domain_scores_codex":[0.9934239,0.0009194039,0.002836773,0.0005732474,0.001524118,0.0007225765],"domain_scores_gemma":[0.9905489,0.004462459,0.002710725,0.001215728,0.0006303894,0.0004317915],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001865452,0.0003182905,0.0004478495,0.04839402,0.0005584268,0.0005338882,0.0003425686,0.000002611786,0.0009446336,0.00007594992,0.003171183,0.9433451],"study_design_scores_gemma":[0.002280631,0.002389626,0.008259094,0.06819973,0.002878565,0.005209863,0.00007259303,0.00004216429,0.00004686964,0.0004466027,0.9096345,0.0005398043],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002402224,0.99407,0.0003272688,0.0005260888,0.0007008507,0.001498728,0.0002027962,0.00002400453,0.0002480187],"genre_scores_gemma":[0.004632098,0.977652,0.01534735,0.00002667907,0.001904721,0.00007899275,0.0001302675,0.0001073976,0.0001205475],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9428053,"threshold_uncertainty_score":0.9997465,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107889478","doi":"10.1016/j.jcf.2012.05.001","title":"Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis","year":2012,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Canadian Child Health Clinician Scientist Program; Ontario Research Foundation; Ontario Genomics Institute; Genome Canada; Cystic Fibrosis Foundation","keywords":"Pancreatitis; Cystic fibrosis transmembrane conductance regulator; Cystic fibrosis; Medicine; Pancreatic disease; Genotype; Hereditary pancreatitis; Phenotype; Internal medicine; Pancreas; Genotype-phenotype distinction; Acute pancreatitis; Mutation; Gastroenterology; Biology; Gene; Genetics; Trypsinogen","retraction":null,"screen_n_in":null,"score":{"opus":0.04129233476501279,"gpt":0.3448053825443447,"spread":0.303513047779332,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001408567,0.00104916,0.005587526,0.00169018,0.0001543131,0.0001316697,0.0007218571,0.000689836,0.0008917654],"category_scores_gemma":[0.002273664,0.0008321354,0.001664583,0.001940101,0.0004653356,0.000704099,0.00009368156,0.001865526,0.0001682127],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001192295,"about_ca_system_score_gemma":0.002124638,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004935287,"about_ca_topic_score_gemma":0.00001806008,"domain_scores_codex":[0.9918233,0.0006772215,0.003645168,0.0006773003,0.001882427,0.001294641],"domain_scores_gemma":[0.9921926,0.0030716,0.002011081,0.0009478837,0.0007144561,0.00106241],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001476576,0.001108289,0.000205075,0.09828227,0.001853271,0.001614642,0.0005090805,0.00009235244,0.009540655,0.0001707436,0.002140298,0.8830068],"study_design_scores_gemma":[0.003438476,0.001721598,0.001410638,0.07450572,0.008729528,0.01102088,0.00008404657,0.00005174948,0.0005020153,0.0002635763,0.897186,0.001085766],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009483909,0.9941278,0.001528141,0.0001370155,0.000813184,0.001527764,0.0006137931,0.00004958945,0.0002543136],"genre_scores_gemma":[0.003047777,0.9119132,0.08237417,0.00003815824,0.001268283,0.0001505986,0.0002705703,0.0002479485,0.0006892638],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8950457,"threshold_uncertainty_score":0.999413,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2104629765","doi":"10.1016/j.jcf.2010.03.001","title":"Alveolar inflammation in cystic fibrosis","year":2010,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute","keywords":"Cystic fibrosis; Medicine; Inflammation; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.009469721526366109,"gpt":0.2921215538409374,"spread":0.2826518323145713,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001297312,0.0002850358,0.0007646855,0.000858005,0.00008600312,0.00009749892,0.0003341997,0.0002232048,0.0006697939],"category_scores_gemma":[0.005670207,0.0002348955,0.0003057086,0.0007672572,0.0002013112,0.000628748,0.00008320737,0.001285193,0.0001049046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002083358,"about_ca_system_score_gemma":0.0004529322,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000466562,"about_ca_topic_score_gemma":0.00006626586,"domain_scores_codex":[0.9964988,0.0001298646,0.001304689,0.0002729937,0.001226362,0.0005673437],"domain_scores_gemma":[0.9968507,0.001021593,0.0005755615,0.0004577743,0.0006214465,0.0004729144],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.002046071,0.0002041855,0.02765584,0.0004527486,0.00008059075,0.0002405973,0.0003101567,0.0002138131,0.9481212,0.0002358723,0.001732994,0.01870593],"study_design_scores_gemma":[0.01068177,0.004953853,0.6423821,0.003333358,0.0005523336,0.003547797,0.0004977715,0.003873453,0.2283442,0.005078742,0.09589996,0.0008546805],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929659,0.0009313955,0.002769433,0.001366248,0.0007594756,0.0004132163,0.00002134331,0.00003529673,0.000737639],"genre_scores_gemma":[0.8949388,0.00005785607,0.1038803,0.00005747282,0.0007628386,0.0000208209,0.00001229397,0.00004581398,0.000223797],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.719777,"threshold_uncertainty_score":0.9578761,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2036284350","doi":"10.1016/j.jcf.2008.10.004","title":"Mechanism of direct bicarbonate transport by the CFTR anion channel","year":2008,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"Cystic Fibrosis Foundation","keywords":"Cystic fibrosis; Bicarbonate; Biophysics; Ion transporter; Chloride channel; Chemistry; Cystic fibrosis transmembrane conductance regulator; Patch clamp; Membrane transport; DIDS; Cell biology; Biochemistry; Membrane; Biology; Medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01547144562847874,"gpt":0.26527039543147,"spread":0.2497989498029913,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006776157,0.0001977474,0.0006758411,0.0002071712,0.0001143504,0.000007760046,0.0002863681,0.00009161283,0.0001042644],"category_scores_gemma":[0.0005444938,0.0001204876,0.0003409513,0.0004276332,0.0002662683,0.0001649235,0.00002800472,0.0003935942,0.00000642209],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008803963,"about_ca_system_score_gemma":0.0002347697,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005616085,"about_ca_topic_score_gemma":0.000002494559,"domain_scores_codex":[0.9973497,0.00009938043,0.0008145637,0.0001718574,0.001216886,0.0003475829],"domain_scores_gemma":[0.9980311,0.0004847918,0.0004907124,0.0003041012,0.0004385786,0.000250715],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003356473,0.0005218079,0.001259403,0.0003986438,0.0004076775,0.0002941001,0.0009602219,0.0001364026,0.9797536,0.0002208468,0.0107745,0.001916335],"study_design_scores_gemma":[0.01115412,0.01392524,0.09196427,0.003091707,0.00139421,0.009289264,0.000889523,0.002827097,0.820832,0.003950102,0.03986653,0.0008159933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9710525,0.009053956,0.01319795,0.002629522,0.0006279461,0.0006430718,0.0001476169,0.00004304254,0.002604438],"genre_scores_gemma":[0.9931068,0.0005917723,0.005417265,0.00008555041,0.0001906078,0.000006491322,0.000007521467,0.00003318715,0.0005608228],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1589217,"threshold_uncertainty_score":0.4913341,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3147967992","doi":"10.1016/j.jcf.2021.03.011","title":"Elexacaftor co-potentiates the activity of F508del and gating mutants of CFTR","year":2021,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canada Research Chairs; National Institute of Diabetes and Digestive and Kidney Diseases; Cystic Fibrosis Canada; Canadian Institutes of Health Research; Cystic Fibrosis Foundation Therapeutics","keywords":"Medicine; Cystic fibrosis; Gating; Mutant; Pharmacology; Internal medicine; Genetics; Physiology; Biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01701565683145318,"gpt":0.3203274993903192,"spread":0.3033118425588661,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006683445,0.0001333038,0.0006153864,0.0001201616,0.00006783399,0.00002352175,0.0001379007,0.00006339736,0.0001288223],"category_scores_gemma":[0.003564143,0.00008640745,0.0001862947,0.0003070105,0.0002918099,0.0001766089,0.00007554815,0.0003280503,0.000001456883],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005475722,"about_ca_system_score_gemma":0.0003771479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002140225,"about_ca_topic_score_gemma":0.000002311286,"domain_scores_codex":[0.9979991,0.0001520884,0.0006544813,0.000138338,0.000821621,0.0002343872],"domain_scores_gemma":[0.9967951,0.001377029,0.0006946612,0.0002477292,0.0007289653,0.0001565509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008521639,0.0001613734,0.01023193,0.0006154216,0.0002000767,0.00005891482,0.0001424313,0.00003502331,0.97676,0.00002845818,0.0003030223,0.01061121],"study_design_scores_gemma":[0.00157783,0.001043672,0.2173088,0.001331787,0.0002807147,0.0008068699,0.0006171244,0.0007150117,0.775413,0.0003287076,0.000487232,0.0000892355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940082,0.00360098,0.001535967,0.0004193151,0.00006244994,0.0001247091,0.00004373333,0.000004374651,0.0002002413],"genre_scores_gemma":[0.9808073,0.0002203411,0.01872853,0.00002435133,0.000109266,0.000001541929,0.000001738362,0.00001633242,0.00009061852],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2070769,"threshold_uncertainty_score":0.4266869,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152066083","doi":"10.1016/j.jcf.2009.09.002","title":"Prevalence of dyslipidemia in adults with cystic fibrosis","year":2009,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Dyslipidemia; Medicine; Cystic fibrosis; Internal medicine; Diabetes mellitus; Triglyceride; Gastroenterology; Cholesterol; Lipid profile; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.009278990793696325,"gpt":0.2862447689766395,"spread":0.2769657781829432,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009000783,0.0003279002,0.001067284,0.0006818917,0.00004792882,0.00002781523,0.0003965761,0.0001499247,0.0001990892],"category_scores_gemma":[0.00294827,0.0002370007,0.0002501415,0.0009184243,0.0002471845,0.000445436,0.00004469593,0.0006635792,0.00001327273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002804481,"about_ca_system_score_gemma":0.0004876309,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002130486,"about_ca_topic_score_gemma":0.000007677772,"domain_scores_codex":[0.9959629,0.0001666484,0.001470644,0.0003380595,0.001457873,0.000603847],"domain_scores_gemma":[0.9963847,0.001080095,0.0008800373,0.0004893355,0.0007336852,0.0004321479],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.08530777,0.002834297,0.2224316,0.01591402,0.0004484268,0.001241405,0.002582558,0.004035594,0.6027409,0.0004299442,0.006468948,0.0555645],"study_design_scores_gemma":[0.008190827,0.01703588,0.9289005,0.02084834,0.0004184039,0.0008651268,0.0003211198,0.001094571,0.02056096,0.0007607176,0.0006124261,0.000391106],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887007,0.005159889,0.003736246,0.0009771044,0.0001523782,0.0005924516,0.00005042832,0.00002647349,0.0006042944],"genre_scores_gemma":[0.9097786,0.0001628359,0.08952618,0.0000887819,0.000199486,0.000006607896,0.000003823703,0.00002969225,0.0002040065],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7064689,"threshold_uncertainty_score":0.9664608,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1996197399","doi":"10.1016/j.jcf.2015.02.005","title":"Cystic fibrosis microbiology: Advances in antimicrobial therapy","year":2015,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Medicine; Antimicrobial; Antibiotics; Cystic fibrosis; Tobramycin; Colistin; Pseudomonas aeruginosa; Amikacin; Antibiotic resistance; Microbiology; Aztreonam; Ciprofloxacin; Intensive care medicine; Gentamicin; Internal medicine; Bacteria; Biology; Imipenem","retraction":null,"screen_n_in":null,"score":{"opus":0.03495323621380664,"gpt":0.3670257421778516,"spread":0.332072505964045,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020072,0.001102833,0.006380466,0.00188992,0.00009763931,0.0001256213,0.0009876314,0.0008119908,0.0002200352],"category_scores_gemma":[0.002326998,0.0007779728,0.001618124,0.001580495,0.000520037,0.0006038844,0.0002149352,0.002110382,0.0001716978],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001193028,"about_ca_system_score_gemma":0.003255272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001670465,"about_ca_topic_score_gemma":0.000009076908,"domain_scores_codex":[0.9929758,0.0008362758,0.003289353,0.0007574169,0.0009647787,0.00117636],"domain_scores_gemma":[0.9932753,0.001937382,0.002320151,0.000811036,0.0009497149,0.000706387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002606744,0.0006107067,0.00005734065,0.02958737,0.0005208504,0.000716844,0.0001117497,0.00002449263,0.00485089,0.00001189728,0.01285139,0.9480497],"study_design_scores_gemma":[0.003126003,0.002614671,0.00003309501,0.05315182,0.0009750661,0.005612547,0.00003655376,0.000006554907,0.0001496425,0.000101676,0.933575,0.0006173728],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002567459,0.9960613,0.0003059467,0.0001235056,0.001185903,0.001382611,0.000394491,0.00004144608,0.0002480624],"genre_scores_gemma":[0.0001329373,0.9690554,0.02898563,0.00007942465,0.001058117,0.0000467293,0.000184092,0.0001841488,0.0002735823],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9474323,"threshold_uncertainty_score":0.9994671,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2159671628","doi":"10.1016/j.jcf.2012.05.003","title":"Long term effects of denufosol tetrasodium in patients with cystic fibrosis","year":2012,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; University of Toronto","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Cystic fibrosis; Placebo; Exacerbation; Pulmonary function testing; Internal medicine; Clinical endpoint; Incidence (geometry); Adverse effect; Randomized controlled trial","retraction":null,"screen_n_in":null,"score":{"opus":0.006414006082338955,"gpt":0.2627376321898389,"spread":0.2563236261075,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005859752,0.0003518112,0.0010683,0.0007044415,0.00005902873,0.00003356031,0.0002942074,0.0001527291,0.0001028284],"category_scores_gemma":[0.002613418,0.0002529055,0.0002421812,0.0007410665,0.0002462793,0.0006654541,0.00008748138,0.0005870471,0.00002118821],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003366254,"about_ca_system_score_gemma":0.0002372342,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001934084,"about_ca_topic_score_gemma":0.000005641815,"domain_scores_codex":[0.9961095,0.0001857007,0.001102644,0.0002340085,0.001547137,0.0008210459],"domain_scores_gemma":[0.9959265,0.001731894,0.0007471595,0.0004237786,0.0005676895,0.0006029967],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00554479,0.001359326,0.93545,0.002502302,0.0002067716,0.00007494463,0.0003549212,0.00004009073,0.04932706,0.00001048174,0.0003305236,0.004798796],"study_design_scores_gemma":[0.006717338,0.004953911,0.9533587,0.004315186,0.0004087465,0.0001359819,0.00004195718,0.00001597522,0.02966813,0.00002361077,0.0001266298,0.0002338181],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935184,0.002942002,0.002254996,0.00006465505,0.0004090504,0.0006726365,0.0000223494,0.00001617576,0.00009980289],"genre_scores_gemma":[0.9753964,0.00003460026,0.02411312,0.00003464935,0.0002680172,0.00001526035,0.00001307112,0.00005959068,0.00006527934],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02185813,"threshold_uncertainty_score":0.9999923,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2083803328","doi":"10.1016/s1569-1993(03)00097-3","title":"Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein","year":2003,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Montreal Children's Hospital; Hamilton Health Sciences","funders":"","keywords":"Glutathione; Cystic fibrosis; Medicine; Oxidative stress; Lung; Internal medicine; Placebo; Lymphocyte; Endocrinology; Gastroenterology; Physiology; Immunology; Pathology; Biochemistry; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.005432454956054489,"gpt":0.2489870439191758,"spread":0.2435545889631213,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006327092,0.0005238481,0.001080864,0.0007237496,0.0001375256,0.0001200324,0.0002485038,0.0001420107,0.0003077624],"category_scores_gemma":[0.002816741,0.0003530095,0.0001691792,0.001160506,0.0002492211,0.0006294271,0.00005202826,0.000830299,0.00001338022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007182088,"about_ca_system_score_gemma":0.0009152188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002920724,"about_ca_topic_score_gemma":0.0004446603,"domain_scores_codex":[0.9947886,0.0002992614,0.001339059,0.0004950112,0.001891551,0.001186536],"domain_scores_gemma":[0.9957794,0.0003393742,0.0008493239,0.0005097721,0.001776761,0.0007453717],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0524216,0.003130744,0.6464633,0.002102827,0.0008212461,0.0005159435,0.0012081,0.000485356,0.289158,0.0002572088,0.0009377851,0.002497958],"study_design_scores_gemma":[0.06698564,0.04534921,0.8195933,0.009683723,0.001026963,0.001039915,0.00205307,0.001142482,0.04833657,0.0003492201,0.002953053,0.001486864],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889611,0.0004234987,0.007928715,0.0002568594,0.000132936,0.001813318,0.0001665024,0.00003641886,0.0002806632],"genre_scores_gemma":[0.8538994,0.00002390878,0.1455387,0.00004698365,0.0000673642,0.00007848375,0.00005701984,0.00009058088,0.00019761],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2408214,"threshold_uncertainty_score":0.9998922,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2110961503","doi":"10.1016/j.jcf.2009.08.004","title":"Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: A review","year":2009,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Tobramycin; Medicine; Cystic fibrosis; Aminoglycoside; Pseudomonas aeruginosa; Antibiotics; Regimen; Drug; Intensive care medicine; Internal medicine; Microbiology; Pharmacology; Gentamicin; Bacteria; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.03754425588828723,"gpt":0.3621503798056651,"spread":0.3246061239173779,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002614903,0.001535968,0.009142094,0.001995973,0.0001294696,0.0001658907,0.00127659,0.0007089631,0.0003209104],"category_scores_gemma":[0.005043113,0.001101058,0.003011656,0.002553877,0.0003124721,0.0004967842,0.0001729047,0.003006769,0.0002030214],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001439988,"about_ca_system_score_gemma":0.002820105,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001990399,"about_ca_topic_score_gemma":0.000006194367,"domain_scores_codex":[0.9884322,0.001141789,0.005304326,0.0009622878,0.002698519,0.001460892],"domain_scores_gemma":[0.9905254,0.002825621,0.003345049,0.001416506,0.0008505176,0.00103691],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006909397,0.0005499814,0.00002302637,0.08670311,0.0004649248,0.00158765,0.00004197144,0.000008458729,0.0002001189,0.000011985,0.01401084,0.895707],"study_design_scores_gemma":[0.001793588,0.002011332,0.0001664292,0.3510968,0.001610135,0.002887835,0.00001413211,0.000007997689,0.00002811755,0.00008557441,0.639698,0.000600043],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007291736,0.9949778,0.0002142555,0.0004844481,0.0005036904,0.003029873,0.0001335634,0.0000631979,0.0005202518],"genre_scores_gemma":[0.00006403415,0.9730694,0.02428019,0.0007128034,0.0009693457,0.0002260521,0.0001366621,0.0002155021,0.0003259963],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.895107,"threshold_uncertainty_score":0.9997389,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2893550035","doi":"10.1016/j.jcf.2018.08.014","title":"Defining antimicrobial resistance in cystic fibrosis","year":2018,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation","funders":"European Cystic Fibrosis Society; Novo Nordisk Fonden; Cystic Fibrosis in Australia; Cystic Fibrosis Canada; Cystic Fibrosis Trust; Cystic Fibrosis Foundation","keywords":"Cystic fibrosis; Medicine; Intensive care medicine; Lung infection; Antibiotic resistance; Antimicrobial; Lung; Internal medicine; Antibiotics; Microbiology","retraction":null,"screen_n_in":null,"score":{"opus":0.02600492107384264,"gpt":0.3443464065453376,"spread":0.318341485471495,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001991759,0.000991596,0.005415218,0.001982754,0.0001586204,0.0001978857,0.0009391418,0.0006917307,0.0003258276],"category_scores_gemma":[0.006768019,0.0007804238,0.001688587,0.00196072,0.0005107629,0.0004114586,0.0002684502,0.002018071,0.0003374864],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001283544,"about_ca_system_score_gemma":0.002563766,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002050362,"about_ca_topic_score_gemma":0.00004311192,"domain_scores_codex":[0.9919594,0.0006240718,0.003750774,0.0007931239,0.001651847,0.001220784],"domain_scores_gemma":[0.9919195,0.003079117,0.002579479,0.0009518475,0.0008101706,0.0006598915],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00778325,0.001410241,0.000423287,0.310231,0.002165372,0.004358548,0.0005899742,0.00002356344,0.0008795846,0.0004432021,0.1481946,0.5234974],"study_design_scores_gemma":[0.001537807,0.001095514,0.0001761852,0.181848,0.001826886,0.001666073,0.00002285592,0.000006838958,0.0000639873,0.0001641519,0.8110337,0.0005579578],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001503306,0.9961097,0.0005857088,0.0001190968,0.000954179,0.0009260335,0.000270458,0.0000406512,0.0008438462],"genre_scores_gemma":[0.0001912076,0.8699676,0.12759,0.00005206115,0.00108438,0.00005273657,0.00008091746,0.0002036974,0.0007774674],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6628391,"threshold_uncertainty_score":0.9994647,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988327126","doi":"10.1016/j.jcf.2012.04.006","title":"Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis","year":2012,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Abbott Canada","keywords":"Medicine; Cystic fibrosis; Sputum; Exacerbation; Respiratory system; Pulmonary function testing; Internal medicine; Neutrophil elastase; Respiratory disease; Immunology; Gastroenterology; Lung; Pathology; Inflammation","retraction":null,"screen_n_in":null,"score":{"opus":0.01583928335108259,"gpt":0.2917945621444256,"spread":0.275955278793343,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001030138,0.0002738182,0.0008377148,0.001103119,0.00004937594,0.00002331111,0.0002644162,0.0001372588,0.0001513765],"category_scores_gemma":[0.001453328,0.0002135744,0.0001665692,0.001133785,0.0002388815,0.000716514,0.00007807067,0.0005973084,0.00001614604],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003357492,"about_ca_system_score_gemma":0.0004189526,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001406712,"about_ca_topic_score_gemma":0.00003851081,"domain_scores_codex":[0.9966536,0.0002297562,0.001225194,0.0002228141,0.0010312,0.000637451],"domain_scores_gemma":[0.997576,0.0007790027,0.0005675196,0.000386645,0.0003025729,0.0003882328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002136811,0.0007000348,0.7535071,0.0001654113,0.0000941124,0.00002107192,0.0003196513,0.0004654723,0.2395453,0.00005119783,0.0001332899,0.002860557],"study_design_scores_gemma":[0.002245998,0.001796586,0.9743872,0.001624158,0.0001598919,0.0005220994,0.0004438598,0.0001257959,0.01704209,0.0001846743,0.001260671,0.0002070307],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882686,0.0103291,0.0003115024,0.00006792114,0.00006706455,0.0004647501,0.00004492329,0.00001406325,0.0004321014],"genre_scores_gemma":[0.9795402,0.00005283971,0.01997699,0.00007945886,0.0002430059,0.00002419889,0.000005794924,0.00004869873,0.00002883544],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2225032,"threshold_uncertainty_score":0.8709311,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3095678196","doi":"10.1016/j.jcf.2020.10.003","title":"The global impact of SARS-CoV-2 in 181 people with cystic fibrosis","year":2020,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; Cystic Fibrosis Canada","funders":"","keywords":"Cystic fibrosis; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Intensive care medicine; Pathology; Internal medicine; Disease; Infectious disease (medical specialty)","retraction":null,"screen_n_in":null,"score":{"opus":0.02091136047171083,"gpt":0.3328509748064831,"spread":0.3119396143347722,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006314365,0.0003441982,0.001090727,0.0001745522,0.0001045682,0.00009111558,0.0005052724,0.0001105452,0.00005320656],"category_scores_gemma":[0.003445782,0.0001956191,0.0004865607,0.001559348,0.0003113265,0.0003162347,0.0001163564,0.0005745738,0.0000212185],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005733036,"about_ca_system_score_gemma":0.00102707,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003081457,"about_ca_topic_score_gemma":0.0001578096,"domain_scores_codex":[0.9962231,0.0001982182,0.001213116,0.0002873791,0.001414486,0.000663735],"domain_scores_gemma":[0.9965199,0.001274626,0.000754877,0.0004031205,0.0006347852,0.0004127536],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.04880194,0.0006819562,0.2979726,0.001446866,0.001163534,0.0005230973,0.001540197,0.003365081,0.6233089,0.0001937454,0.01347252,0.007529527],"study_design_scores_gemma":[0.01015629,0.02447061,0.9170043,0.002891174,0.0006957948,0.001913968,0.0008975326,0.004971289,0.03205113,0.0008658358,0.003531601,0.0005505176],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897673,0.003009128,0.00356855,0.002547683,0.0001169945,0.0004841457,0.0001124585,0.00002231063,0.0003714696],"genre_scores_gemma":[0.9834281,0.0001142924,0.01605774,0.0001108105,0.0002207418,0.000009061825,0.000005619338,0.00003904265,0.00001458632],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6190317,"threshold_uncertainty_score":0.7977115,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2616696643","doi":"10.1016/j.jcf.2017.05.003","title":"Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis-like lung disease in mice","year":2017,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Ion Transport and Channel Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Epithelial sodium channel; Cystic fibrosis; Medicine; Lung; Mucus; Inhalation; Airway; Fibrosis; Inflammation; Immunology; Pathology; Internal medicine; Biology; Chemistry; Sodium; Anesthesia","retraction":null,"screen_n_in":null,"score":{"opus":0.006855049359668626,"gpt":0.2428059995458305,"spread":0.2359509501861619,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002883471,0.0002106336,0.0003096461,0.0001348682,0.0001799744,0.0001099936,0.0003416118,0.0001383855,0.00002502354],"category_scores_gemma":[0.0002537448,0.0001903103,0.0002200618,0.00007690574,0.0001171463,0.00003797035,0.00005262611,0.0001498466,0.000007608417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003350294,"about_ca_system_score_gemma":0.0001313174,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003045518,"about_ca_topic_score_gemma":0.00002322142,"domain_scores_codex":[0.9985924,0.00006516819,0.0005619144,0.0002324123,0.0002626566,0.0002854481],"domain_scores_gemma":[0.9985892,0.00003322396,0.000580429,0.0003681211,0.0002097768,0.0002193],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001819778,0.0001175198,0.03188192,0.0001959404,0.0000796141,0.0002779848,0.0001075134,0.002254386,0.9605439,0.00001958662,0.00170255,0.0009992945],"study_design_scores_gemma":[0.003544794,0.0005627248,0.7977514,0.000980398,0.0003779643,0.0001783852,0.0001189836,0.003589592,0.1877209,0.0003980585,0.004105537,0.0006712275],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947557,0.001599297,0.002638622,0.0002412392,0.0005278957,0.0001259385,0.00003713018,0.000005823642,0.00006829947],"genre_scores_gemma":[0.9974602,0.000206973,0.001489635,0.00006081396,0.0004343096,0.000003900226,0.00004806126,0.00003064621,0.0002654281],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.772823,"threshold_uncertainty_score":0.7760629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2424357543","doi":"10.1016/j.jcf.2016.05.014","title":"Physiologic endpoints for clinical studies for cystic fibrosis","year":2016,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Cystic fibrosis; Clinical trial; Intensive care medicine; Placebo; Clinical endpoint; Lung disease; Lung function; Disease; Clinical study design; Internal medicine; Lung; Alternative medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1846338040306441,"gpt":0.5055611753703343,"spread":0.3209273713396902,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003019359,0.001061136,0.008556189,0.0007681424,0.0002467463,0.00008723438,0.0008752072,0.0007357679,0.0001037632],"category_scores_gemma":[0.03959009,0.000605514,0.005287718,0.0004717638,0.0006909074,0.0002901521,0.0002592144,0.0009530801,0.00009533932],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007571749,"about_ca_system_score_gemma":0.00164493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":8.305799e-7,"about_ca_topic_score_gemma":6.675742e-7,"domain_scores_codex":[0.9914083,0.0005961125,0.004755445,0.0009169853,0.001125813,0.001197268],"domain_scores_gemma":[0.9621509,0.03025165,0.003733207,0.0008851336,0.002243337,0.0007358106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003770983,0.0003728964,0.000006408588,0.08630081,0.003519606,0.00005083593,0.00003258961,0.000001253777,0.0004642703,0.00007215378,0.0659076,0.8395006],"study_design_scores_gemma":[0.003660923,0.009482168,0.00005053072,0.09377576,0.006262783,0.0005500087,0.00006122544,0.00001312974,0.00004511415,0.001886019,0.8836557,0.000556672],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003349923,0.9814891,0.01092073,0.0002749607,0.00227687,0.003685409,0.001233116,0.00005096851,0.00003537782],"genre_scores_gemma":[0.00003168736,0.875702,0.1182559,0.00007784605,0.004087563,0.0005263484,0.00008751379,0.0001927086,0.001038405],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8389439,"threshold_uncertainty_score":0.9996396,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2032195196","doi":"10.1016/j.jcf.2004.05.039","title":"Animal models of cystic fibrosis","year":2004,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Child and Family Research Institute; BC Research (Canada); University of British Columbia","funders":"","keywords":"Cystic fibrosis; Medicine; Animal model; Phenotype; Pathology; Computational biology; Genetics; Biology; Internal medicine; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.04403635750883467,"gpt":0.3588228530840247,"spread":0.3147864955751901,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001273359,0.001064528,0.006741709,0.001605429,0.0001186361,0.0001003977,0.001011034,0.0007149405,0.0003643753],"category_scores_gemma":[0.002932792,0.0007860206,0.002933302,0.00145847,0.0005134837,0.0005681856,0.0002834215,0.001811041,0.00008446353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001199887,"about_ca_system_score_gemma":0.004090762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004208351,"about_ca_topic_score_gemma":0.000001874498,"domain_scores_codex":[0.9911227,0.0003900148,0.004108252,0.0006554924,0.002695235,0.001028259],"domain_scores_gemma":[0.990873,0.00228953,0.003530875,0.001036206,0.001329834,0.0009406033],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00485749,0.001561041,0.00001654231,0.3451987,0.003661689,0.001276757,0.0003286378,0.001035784,0.004069629,0.0009271716,0.005423626,0.6316429],"study_design_scores_gemma":[0.0039444,0.01033385,0.00009535119,0.3082803,0.01200359,0.007669819,0.000102382,0.000283493,0.0003733748,0.002320913,0.653421,0.001171513],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001115304,0.9915529,0.005693616,0.00008063785,0.0004897106,0.001125745,0.0004060696,0.00004174241,0.0004980301],"genre_scores_gemma":[0.001531726,0.8984603,0.09857181,0.00001833094,0.0007581051,0.00003767608,0.00007132682,0.0002259451,0.0003247654],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6479974,"threshold_uncertainty_score":0.9994591,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2010334051","doi":"10.1016/j.jcf.2007.02.005","title":"Increased glucose excursion in cystic fibrosis and its association with a worse clinical status","year":2007,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal","funders":"Université de Montréal","keywords":"Medicine; Impaired glucose tolerance; Cystic fibrosis; Internal medicine; Cystic fibrosis-related diabetes; Insulin resistance; Endocrinology; Diabetes mellitus; Insulin; Glucose tolerance test; Carbohydrate metabolism; Continuous glucose monitoring; Glycemic","retraction":null,"screen_n_in":null,"score":{"opus":0.01668407460196339,"gpt":0.3356523378849542,"spread":0.3189682632829908,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004433977,0.0002984418,0.0009935509,0.0007091989,0.00009190785,0.00007573311,0.0001574604,0.0002621985,0.0001214072],"category_scores_gemma":[0.01069462,0.0002251626,0.0001853008,0.0008689584,0.0001273049,0.0004620667,0.00007658848,0.0009648304,0.00001796773],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008212262,"about_ca_system_score_gemma":0.0004609501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009815038,"about_ca_topic_score_gemma":0.00009010199,"domain_scores_codex":[0.995308,0.0003291118,0.001601455,0.0003559469,0.001549212,0.0008563128],"domain_scores_gemma":[0.9927184,0.004320891,0.001010559,0.0002524346,0.0007803814,0.0009173131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02808695,0.001019005,0.8724802,0.0006140682,0.0002799039,0.0008531315,0.000396867,0.0000707232,0.07303944,0.00003993962,0.001378744,0.02174104],"study_design_scores_gemma":[0.009308097,0.005938995,0.9669179,0.002542829,0.0003826671,0.0004602165,0.0003560112,0.0006536035,0.008350518,0.0001708984,0.004638007,0.0002803058],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922417,0.004686635,0.00176468,0.0003793239,0.0002262444,0.0004811486,0.00003815502,0.00002539036,0.0001566871],"genre_scores_gemma":[0.9644019,0.0006148001,0.03430386,0.0001114482,0.0003661671,0.000008723553,0.00001344188,0.00004448029,0.0001351626],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09443767,"threshold_uncertainty_score":0.9976387,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390063576","doi":"10.1016/j.jcf.2023.12.002","title":"Standards for the care of people with cystic fibrosis; establishing and maintaining health","year":2023,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Paul's Hospital; University of British Columbia; BC Children's Hospital","funders":"University of Liverpool; National Institute for Health and Care Research","keywords":"Medicine; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Directive; Ivacaftor; Health care; Adverse effect; Intensive care medicine; Pharmacology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03516336676312733,"gpt":0.3834324300092083,"spread":0.348269063246081,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003174713,0.0005949578,0.004001885,0.0007097741,0.0003357337,0.0002063678,0.0005184463,0.0002201289,0.00002462404],"category_scores_gemma":[0.006839217,0.0003332163,0.0007492263,0.001131631,0.000307427,0.0002606052,0.0001930557,0.00105353,0.000001667444],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009579213,"about_ca_system_score_gemma":0.00564648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001229742,"about_ca_topic_score_gemma":0.00008964274,"domain_scores_codex":[0.9943135,0.0003133482,0.002059035,0.0004456368,0.002068285,0.000800163],"domain_scores_gemma":[0.984854,0.009922958,0.002479494,0.0005915569,0.001642623,0.0005093284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002372646,0.00006708463,0.0000706882,0.2121561,0.001452215,0.00006560482,0.002159029,0.0001671933,0.00002842028,0.0001240141,0.004568066,0.7767689],"study_design_scores_gemma":[0.002688203,0.00936153,0.0003938511,0.2043676,0.004896185,0.001725685,0.005306474,0.0001607223,0.00001114722,0.0001190401,0.7705039,0.0004655908],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007514287,0.9801726,0.01547932,0.0003488752,0.0003022191,0.002101821,0.001463532,0.00003129914,0.00002517558],"genre_scores_gemma":[0.0009614697,0.9566692,0.04126656,0.00002995833,0.0005625591,0.0001178135,0.00009152597,0.0002032751,0.00009763424],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7763034,"threshold_uncertainty_score":0.9999906,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390921073","doi":"10.1016/j.jcf.2024.01.005","title":"Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues","year":2024,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"European Cystic Fibrosis Society; National Institute for Health and Care Research","keywords":"Cystic fibrosis; Medicine; Intensive care medicine; Family medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02449578822589046,"gpt":0.3705054148147217,"spread":0.3460096265888312,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001428731,0.0002841893,0.0009227943,0.0003567523,0.0002947217,0.0002413166,0.0001969191,0.00008591214,0.00006257879],"category_scores_gemma":[0.001932591,0.0001669975,0.00024277,0.0005477818,0.0002897053,0.0003365296,0.00006921635,0.0004537675,0.000001234034],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003937366,"about_ca_system_score_gemma":0.001555202,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001314453,"about_ca_topic_score_gemma":0.00006286494,"domain_scores_codex":[0.9967417,0.0001315237,0.0009160482,0.000311671,0.001387896,0.0005112379],"domain_scores_gemma":[0.9948342,0.002842637,0.0004618114,0.0003091995,0.001230251,0.0003218346],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03052477,0.0003903539,0.007795447,0.06616696,0.0028541,0.0002563579,0.03505367,0.001653866,0.1355751,0.0004348397,0.04566753,0.6736271],"study_design_scores_gemma":[0.02502191,0.08595105,0.1351696,0.2145196,0.008991795,0.01054415,0.07039692,0.0265147,0.08350834,0.003757705,0.333003,0.00262125],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.313188,0.5310355,0.1361334,0.01393869,0.001186156,0.002553335,0.001640554,0.0001184843,0.0002059569],"genre_scores_gemma":[0.8941229,0.001402525,0.1036956,0.00006959714,0.0004710263,0.00002261704,0.00001628781,0.00007606691,0.0001234228],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6710058,"threshold_uncertainty_score":0.6809961,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1968592009","doi":"10.1016/j.jcf.2011.10.003","title":"Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis","year":2011,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Cystic fibrosis; Medicine; Exacerbation; Observational study; Lung function; Internal medicine; Lung; Inflammation; Placebo; Intensive care medicine; Gastroenterology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.00918984070391594,"gpt":0.2667864532162647,"spread":0.2575966125123488,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008818238,0.0002371545,0.0007127696,0.0004473034,0.0000585,0.00002464991,0.0001503295,0.0001017692,0.00009305301],"category_scores_gemma":[0.0006748452,0.000140642,0.0002493284,0.0003612734,0.0001762755,0.0002352424,0.00002668024,0.0002161272,0.00000492432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000145406,"about_ca_system_score_gemma":0.00009946543,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000140814,"about_ca_topic_score_gemma":0.000006768629,"domain_scores_codex":[0.9974056,0.000393258,0.0008955121,0.0001845216,0.0008501133,0.0002709482],"domain_scores_gemma":[0.997515,0.001165644,0.0006143258,0.0003120282,0.0002394328,0.0001535398],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.06061939,0.001040658,0.03004773,0.001856222,0.0006499778,0.0002421762,0.004358451,0.0004827178,0.8189715,0.0001497304,0.0002164705,0.08136504],"study_design_scores_gemma":[0.0114795,0.08230858,0.643402,0.00232149,0.001789893,0.0005391935,0.0005565229,0.001308096,0.2551158,0.0006133791,0.0003194665,0.0002460955],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958894,0.002231455,0.0007692894,0.0001055931,0.0001515609,0.0005785591,0.00002367586,0.000006830696,0.000243661],"genre_scores_gemma":[0.9967683,0.0001273619,0.002816015,0.00000753688,0.000199154,0.00002120821,0.00000628398,0.00002067446,0.00003346153],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6133543,"threshold_uncertainty_score":0.5735213,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2096694356","doi":"10.1016/j.jcf.2015.01.007","title":"Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients","year":2015,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; St. Paul's Hospital; St. Michael's Hospital; BC Children's Hospital; Hamilton Health Sciences; University of Toronto; SickKids Foundation; University of British Columbia; Hospital for Sick Children; Providence Health Care","funders":"","keywords":"Medicine; Sputum; Exacerbation; Cystic fibrosis; Internal medicine; Neutrophil elastase; Antibiotics; Gastroenterology; Pulmonary function testing; Lung; Inflammation; Pathology; Tuberculosis","retraction":null,"screen_n_in":null,"score":{"opus":0.04270354317950472,"gpt":0.3141411249645583,"spread":0.2714375817850536,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006916225,0.0003116161,0.0009640157,0.000904967,0.0000522092,0.00003074329,0.0001892004,0.0001165501,0.00006139866],"category_scores_gemma":[0.007632238,0.0002101862,0.0001950823,0.00115364,0.0001282415,0.0002771818,0.00004502679,0.0002003595,0.00000870744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001512223,"about_ca_system_score_gemma":0.0007699308,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006412428,"about_ca_topic_score_gemma":0.00003184419,"domain_scores_codex":[0.9964793,0.0003805315,0.001039083,0.0002570238,0.001379053,0.0004650287],"domain_scores_gemma":[0.9951468,0.002034041,0.00056499,0.0003402216,0.001184952,0.0007290533],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04589928,0.004426073,0.8847131,0.0001590506,0.0004456339,0.0001898578,0.003298558,0.00317257,0.05154449,0.000005886929,0.001021432,0.00512406],"study_design_scores_gemma":[0.006352825,0.02093908,0.9605066,0.0015993,0.0002823468,0.00003010521,0.0008003172,0.0002730334,0.007133863,0.00006900782,0.001790304,0.0002232747],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975573,0.0005216872,0.0005135701,0.0003453021,0.0001413281,0.0006287752,0.000163305,0.00001721483,0.0001114477],"genre_scores_gemma":[0.9928834,0.00001261599,0.006605645,0.00001831514,0.00005282534,0.00003187981,0.00004003173,0.00004519309,0.00031004],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07579344,"threshold_uncertainty_score":0.9137053,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2092060784","doi":"10.1016/j.jcf.2011.07.008","title":"Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis","year":2011,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Infections and bacterial resistance","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network; SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Stenotrophomonas maltophilia; Exacerbation; Cystic fibrosis; Internal medicine; Burkholderia cepacia complex; Retrospective cohort study; Gastroenterology; Pseudomonas aeruginosa; Burkholderia","retraction":null,"screen_n_in":null,"score":{"opus":0.009209945613618674,"gpt":0.2311103378379804,"spread":0.2219003922243617,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002243133,0.0001361944,0.0002243159,0.0001242009,0.00006029434,0.00002873599,0.00006989505,0.0001281999,0.00005801125],"category_scores_gemma":[0.0001696017,0.0001154424,0.00009865322,0.0001052199,0.00005413041,0.00002217261,0.00003708833,0.000109171,0.000004065285],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007918623,"about_ca_system_score_gemma":0.00008735465,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009473258,"about_ca_topic_score_gemma":0.00009626601,"domain_scores_codex":[0.9990801,0.00007242642,0.0004041778,0.0001508914,0.0001203022,0.0001721084],"domain_scores_gemma":[0.9993826,0.00002797862,0.0002664425,0.0001394416,0.0001175893,0.00006590721],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0005174385,0.000106505,0.1276052,0.0001024468,0.00006719754,0.000008986507,0.0000865531,0.00006956951,0.8676124,0.00008638324,0.0001001773,0.003637166],"study_design_scores_gemma":[0.001043892,0.001882675,0.9349738,0.0001304524,0.00007006587,0.00008960317,0.00001719623,0.00003734592,0.05724487,0.0002710846,0.004049602,0.0001893858],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956446,0.0008337914,0.002832714,0.00002952188,0.0003823752,0.0000971147,0.000009367601,0.000004150023,0.0001663476],"genre_scores_gemma":[0.9964762,0.0003498967,0.0026812,0.00001661012,0.0002590551,0.000009013093,0.000005752996,0.00001506823,0.0001871646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8103675,"threshold_uncertainty_score":0.4707604,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2606303288","doi":"10.1016/j.jcf.2017.03.011","title":"CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis","year":2017,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Health and Medical Research Council; Medical Research Council; Children's Health Foundation; Office of Health and Medical Research; Children's Medical Research","keywords":"Cystic fibrosis; Medicine; Phenotype; Cystic fibrosis transmembrane conductance regulator; Exacerbation; Lung; Macrophage; Immunology; Macrophage polarization; Monocyte; Internal medicine; In vitro; Biology; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02107580180820579,"gpt":0.3359458660717523,"spread":0.3148700642635465,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001386648,0.000418557,0.001241483,0.001007849,0.0002006748,0.0002652627,0.0008353422,0.0001878506,0.0003268474],"category_scores_gemma":[0.006893787,0.0003463042,0.0004019771,0.0003890539,0.0003277023,0.0008538921,0.0002664045,0.001058058,0.00005627251],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008091834,"about_ca_system_score_gemma":0.000414275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005132123,"about_ca_topic_score_gemma":0.0001512834,"domain_scores_codex":[0.9956276,0.0002813322,0.001386892,0.0004630276,0.001412562,0.0008285275],"domain_scores_gemma":[0.9961293,0.001070547,0.001132771,0.000789866,0.0004194838,0.0004580321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.008980502,0.0009045333,0.1664089,0.0008078134,0.0003100624,0.004020555,0.0005624556,0.0009173519,0.7976933,0.0000620639,0.0007025885,0.01862985],"study_design_scores_gemma":[0.009905558,0.002940864,0.8385962,0.004554312,0.0001892318,0.001089067,0.0002978902,0.0007031482,0.1382664,0.001114156,0.001869357,0.0004738077],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935347,0.002815393,0.0008720559,0.0008240028,0.0005044182,0.0005570621,0.00005841264,0.00002332701,0.0008105896],"genre_scores_gemma":[0.978821,0.0002743989,0.02008175,0.00004805155,0.0002819865,0.00003481925,0.000006257878,0.00006583239,0.000385865],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6721873,"threshold_uncertainty_score":0.9998989,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2253886635","doi":"10.1016/j.jcf.2015.12.004","title":"A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients","year":2016,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"University of North Carolina at Chapel Hill; Hospital for Sick Children; University of Washington","keywords":"Medicine; Exacerbation; Placebo; Levofloxacin; Cystic fibrosis; Internal medicine; Adverse effect; Clinical endpoint; Randomized controlled trial; Inhalation; Antibiotics; Anesthesia; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03195030563947034,"gpt":0.3543271298716487,"spread":0.3223768242321784,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005281281,0.0003808687,0.001728022,0.0008987606,0.000170776,0.00006738027,0.0002769951,0.00009804891,0.00008449903],"category_scores_gemma":[0.01099211,0.0002075293,0.0003171158,0.0006479534,0.000253853,0.0005193823,0.0001592087,0.0003371307,0.00001346589],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004850343,"about_ca_system_score_gemma":0.0003017934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009590872,"about_ca_topic_score_gemma":0.0000594595,"domain_scores_codex":[0.9938167,0.001145658,0.002355312,0.0004085461,0.001752945,0.0005207983],"domain_scores_gemma":[0.9905197,0.006257014,0.001004769,0.0003905646,0.001481555,0.0003463778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9302309,0.008180811,0.004360582,0.000151587,0.0004570067,0.00001057591,0.001283956,0.0004695677,0.04759483,0.00001333445,0.0001789876,0.00706789],"study_design_scores_gemma":[0.9620447,0.00546516,0.02061965,0.001793998,0.0006370442,0.00002916533,0.0002894857,0.0068226,0.001934447,0.00004724302,0.0001016238,0.000214851],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9632775,0.0005898741,0.02783319,0.0008843005,0.0002455487,0.007039988,0.00008820031,0.00001518057,0.00002621212],"genre_scores_gemma":[0.9892949,0.00008793667,0.01009651,0.00003298288,0.0001111342,0.0001924295,0.00001826836,0.00004066659,0.0001251388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04566038,"threshold_uncertainty_score":0.9973387,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3129853356","doi":"10.1016/j.jcf.2021.02.003","title":"PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy","year":2021,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Cystic Fibrosis Foundation","keywords":"Ivacaftor; Medicine; Milestone; Cystic fibrosis; Observational study; Intensive care medicine; Healthcare delivery; Health care; Pathology; Internal medicine; Cystic fibrosis transmembrane conductance regulator","retraction":null,"screen_n_in":null,"score":{"opus":0.1929809687188107,"gpt":0.4687643287808876,"spread":0.2757833600620769,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007052722,0.0005720077,0.003188117,0.0008290125,0.0007097745,0.0002976391,0.0005407938,0.0002880051,0.000014798],"category_scores_gemma":[0.002763948,0.0002735535,0.0005543537,0.002102448,0.0007787914,0.0001488896,0.0001988234,0.003221275,0.000001639547],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004824205,"about_ca_system_score_gemma":0.001459326,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003675055,"about_ca_topic_score_gemma":0.00002341632,"domain_scores_codex":[0.9928386,0.003265266,0.001200724,0.0004054852,0.001543434,0.0007464546],"domain_scores_gemma":[0.9801475,0.01603364,0.0007634942,0.0008215572,0.001603004,0.0006307641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01200772,0.0004442119,0.0002893734,0.01102298,0.003120437,0.000144343,0.00130967,0.00002165351,0.0001557874,0.00004818962,0.002010611,0.969425],"study_design_scores_gemma":[0.009528396,0.03976575,0.001397527,0.187798,0.003765222,0.001706221,0.006562557,0.00004822175,0.0001452833,0.0001284625,0.7484142,0.0007401067],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0177845,0.9724181,0.003595225,0.0007534833,0.00009526448,0.00522846,0.00004088366,0.00002130723,0.00006272989],"genre_scores_gemma":[0.01415792,0.9614316,0.02269306,0.00007408822,0.0007573432,0.0003458596,0.00003081112,0.0002153524,0.000293925],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9686849,"threshold_uncertainty_score":0.9999717,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2049260196","doi":"10.1016/j.jcf.2014.12.013","title":"A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients","year":2015,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"University of North Carolina at Chapel Hill; Hospital for Sick Children; University of Washington","keywords":"Medicine; Tobramycin; Levofloxacin; Cystic fibrosis; Inhalation; Exacerbation; Clinical endpoint; Dysgeusia; Adverse effect; Internal medicine; Aztreonam; Pseudomonas aeruginosa; Randomized controlled trial; Anesthesia; Antibiotics; Ceftazidime","retraction":null,"screen_n_in":null,"score":{"opus":0.05925007916964949,"gpt":0.3767043905778113,"spread":0.3174543114081618,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006701646,0.000347313,0.001489994,0.0006858836,0.0001710126,0.000145588,0.0003435066,0.0001778181,0.00004917139],"category_scores_gemma":[0.01827495,0.0002469894,0.000175102,0.001052263,0.000252774,0.0009640557,0.0002598762,0.0004727323,0.00001284552],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008902685,"about_ca_system_score_gemma":0.0007381749,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000331337,"about_ca_topic_score_gemma":0.00005711944,"domain_scores_codex":[0.9937443,0.001343279,0.002215959,0.0003895496,0.001775917,0.0005310214],"domain_scores_gemma":[0.9930321,0.003612954,0.001063992,0.0004126069,0.001391391,0.0004869651],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9452543,0.001764305,0.0001441724,0.0001356398,0.000171093,0.000006187525,0.0009874493,0.001278638,0.03166279,0.00005128502,0.000958859,0.01758526],"study_design_scores_gemma":[0.9422749,0.01618833,0.002897964,0.001165047,0.0006561524,0.00002454208,0.0001878296,0.03269689,0.002753733,0.000382,0.0005218494,0.0002508048],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.960474,0.0009045367,0.03165939,0.001194233,0.0008313621,0.004651782,0.00006634755,0.0000170192,0.0002013189],"genre_scores_gemma":[0.9809443,0.00007547189,0.01844667,0.00003998559,0.0002406269,0.00006721078,0.00008458963,0.00003918642,0.00006196263],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03141825,"threshold_uncertainty_score":0.9999982,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2946708745","doi":"10.1016/j.jcf.2019.05.013","title":"Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections","year":2019,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Micropharma (Canada)","funders":"National Institutes of Health; ZonMw; Cystic Fibrosis Foundation Therapeutics","keywords":"Medicine; Clofazimine; Inhalation; Nontuberculous mycobacteria; Cystic fibrosis; Aerosolization; Aerosol; Pulmonary disease; Mycobacterium; Dermatology; Tuberculosis; Anesthesia; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01729605973162496,"gpt":0.2875554166532426,"spread":0.2702593569216177,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002537692,0.0001298676,0.0004193763,0.0001460076,0.00006922952,0.00002396238,0.00006960254,0.00008496458,0.0002954655],"category_scores_gemma":[0.0003904936,0.00007497091,0.0003287555,0.0001611181,0.00004180019,0.0001348158,0.00001799497,0.0000932205,0.00001788862],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001502374,"about_ca_system_score_gemma":0.0001867139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006725979,"about_ca_topic_score_gemma":0.000005902235,"domain_scores_codex":[0.9987864,0.000051255,0.0005148741,0.0001100621,0.0003381996,0.0001991698],"domain_scores_gemma":[0.9977106,0.0011219,0.0003266038,0.0002323371,0.0004718419,0.0001367384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.006373222,0.001220101,0.07350864,0.0002881048,0.0003700222,0.00002474116,0.0002302194,0.0001316908,0.9016953,0.0000401807,0.001663384,0.01445444],"study_design_scores_gemma":[0.0140525,0.03642016,0.7061039,0.00123051,0.002227623,0.001883269,0.0003088549,0.004112295,0.2158016,0.0001806489,0.01733545,0.0003431676],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963593,0.0004844992,0.0005210828,0.0008212017,0.0007397746,0.000785877,0.00003834595,0.000007275118,0.0002426547],"genre_scores_gemma":[0.9975534,0.0005020137,0.000951393,0.00002922479,0.0006570416,0.00002475586,0.00002543911,0.00001768427,0.0002390186],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6858936,"threshold_uncertainty_score":0.323514,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2994781405","doi":"10.1016/j.jcf.2019.12.001","title":"Functional rescue of c.3846G>A (W1282X) in patient-derived nasal cultures achieved by inhibition of nonsense mediated decay and protein modulators with complementary mechanisms of action","year":2019,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Cystic Fibrosis Canada; Canadian Institutes of Health Research; Hospital for Sick Children; Cystic Fibrosis Foundation Therapeutics","keywords":"Medicine; Cystic fibrosis; Nonsense; Action (physics); Pharmacology; Internal medicine; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01050388718971888,"gpt":0.2579854291886858,"spread":0.247481541998967,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004097123,0.000189365,0.0006859406,0.0003899493,0.00002894099,0.000007900914,0.00006419757,0.00009643406,0.0001253294],"category_scores_gemma":[0.0002859478,0.0001390224,0.0001012125,0.0003654517,0.000177391,0.0002575238,0.00004600812,0.0002766529,9.80101e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001300854,"about_ca_system_score_gemma":0.0001917161,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001350249,"about_ca_topic_score_gemma":0.00006061149,"domain_scores_codex":[0.9973199,0.0001700469,0.001013014,0.0001937838,0.001081474,0.000221752],"domain_scores_gemma":[0.9979745,0.0002961371,0.0008424584,0.0001680955,0.0005712738,0.0001475414],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01188863,0.000357159,0.002887955,0.0006608934,0.0001592948,0.00001245979,0.0002701185,0.0003529879,0.9826972,0.00005623767,0.0002414063,0.0004155907],"study_design_scores_gemma":[0.006189453,0.006943971,0.05378086,0.001984532,0.0001036216,0.000126921,0.001130998,0.000469269,0.9288443,0.0002618216,0.00004101718,0.0001231785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957648,0.0002641426,0.002814274,0.0001949146,0.00006820088,0.0007102781,0.0001629987,0.000005887787,0.00001448642],"genre_scores_gemma":[0.9838139,0.00002526876,0.01599654,0.00001601518,0.00002172556,0.000009240951,0.00008198633,0.00002192523,0.00001343016],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05385292,"threshold_uncertainty_score":0.566917,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2155809148","doi":"10.1016/j.jcf.2014.03.011","title":"European Cystic Fibrosis Society Standards of Care: Quality Management in cystic fibrosis","year":2014,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"","keywords":"Cystic fibrosis; Medicine; Patient registry; Quality management; Health care; Patient care; Family medicine; Quality (philosophy); Intensive care medicine; Pediatrics; Internal medicine; Nursing; Operations management; Management system; Economic growth","retraction":null,"screen_n_in":null,"score":{"opus":0.03030238189783578,"gpt":0.3822643040077034,"spread":0.3519619221098676,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.007549303,0.001617485,0.008586768,0.00157091,0.0002219249,0.0002183082,0.001639212,0.0006590799,0.0003669773],"category_scores_gemma":[0.004817684,0.001295647,0.004374496,0.002275721,0.0007404416,0.0004108518,0.000767478,0.002367608,0.00008565762],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003238782,"about_ca_system_score_gemma":0.001905538,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007914011,"about_ca_topic_score_gemma":0.00001805933,"domain_scores_codex":[0.9823934,0.002752688,0.006907548,0.001258376,0.005094673,0.001593269],"domain_scores_gemma":[0.9860052,0.004176033,0.004896102,0.001917211,0.001970167,0.001035216],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002837815,0.0007289961,0.0001800365,0.3281013,0.002734977,0.0004982601,0.0008638145,0.0002353974,0.0003843697,0.0001767989,0.0113076,0.6519507],"study_design_scores_gemma":[0.004188636,0.003648319,0.001214526,0.1203661,0.006450666,0.0005011028,0.00065962,0.00004665605,0.00007810543,0.0001542685,0.8615683,0.00112362],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003397135,0.9864515,0.006514259,0.0000948978,0.0008607708,0.002264816,0.001466667,0.00007651043,0.00193086],"genre_scores_gemma":[0.004267153,0.897632,0.09585751,0.00006309214,0.0009257472,0.0001183492,0.0002691243,0.0004017956,0.0004652087],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8502607,"threshold_uncertainty_score":0.999934,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2206257597","doi":"10.1016/j.jcf.2015.11.005","title":"Predictors of non-referral of patients with cystic fibrosisfor lung transplant evaluation in the United States","year":2015,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; University of Washington; National Institutes of Health; Cystic Fibrosis Foundation","keywords":"Medicine; Cystic fibrosis; Lung transplantation; Referral; Internal medicine; Sputum; Transplantation; Lung; Pediatrics; Intensive care medicine; Family medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03062541038482533,"gpt":0.3144751075072233,"spread":0.283849697122398,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001485382,0.0001370181,0.0004662376,0.0003504957,0.00001990024,0.000008654367,0.0001286079,0.00006483591,0.00001765587],"category_scores_gemma":[0.0002319882,0.00007430261,0.0001030253,0.0004511713,0.00007507071,0.0001313783,0.000004047152,0.0001807887,3.267049e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007106147,"about_ca_system_score_gemma":0.0002391386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008995194,"about_ca_topic_score_gemma":0.00001185475,"domain_scores_codex":[0.9976095,0.0002722964,0.0007963864,0.00008849233,0.001082494,0.0001508162],"domain_scores_gemma":[0.9978713,0.0006042662,0.000516671,0.0001450529,0.000760432,0.0001023227],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007429798,0.0003689944,0.9721522,0.0007443306,0.000236106,0.00001263243,0.01049324,0.006038636,0.001820438,0.00001433562,0.0002405642,0.000448728],"study_design_scores_gemma":[0.007700291,0.002660662,0.9804247,0.001301813,0.001462665,0.00003644067,0.0008858324,0.003873967,0.001464928,0.00006678992,0.00004121753,0.0000806798],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905807,0.0001560145,0.008411879,0.0001403146,0.000160004,0.0004097272,0.0001019092,0.000003330344,0.00003615783],"genre_scores_gemma":[0.9867451,0.00002813641,0.01297616,0.00004625632,0.00004657228,0.000005541311,0.0001334578,0.00001336304,0.000005468956],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009607403,"threshold_uncertainty_score":0.3029973,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2991309768","doi":"10.1016/j.jcf.2019.11.006","title":"Integrating the multiple breath washout test into international multicentre trials","year":2019,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Engineering and Physical Sciences Research Council; National Institute for Health and Care Research; Cystic Fibrosis Foundation Therapeutics","keywords":"Medicine; Cystic fibrosis; Washout; Test (biology); Internal medicine; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01928974385892504,"gpt":0.3356648904360107,"spread":0.3163751465770856,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002311403,0.0002256079,0.0008278478,0.0002507002,0.0001009338,0.0001384669,0.0004810742,0.00008950014,0.0007679468],"category_scores_gemma":[0.03549292,0.000122572,0.0004574367,0.0002691571,0.0001191965,0.0003319999,0.000120277,0.0006306463,0.0001455071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003327166,"about_ca_system_score_gemma":0.0002893239,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006073527,"about_ca_topic_score_gemma":0.00002159825,"domain_scores_codex":[0.9967178,0.0002329894,0.001303475,0.0002140911,0.001197591,0.0003340185],"domain_scores_gemma":[0.9885282,0.009158518,0.0008888775,0.0003626812,0.0008172156,0.000244488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.004227858,0.0005497545,0.14869,0.0003334258,0.0006399276,0.0001020481,0.002086521,0.0003550753,0.7876914,0.0001212134,0.008192441,0.04701035],"study_design_scores_gemma":[0.04978093,0.01149355,0.3823511,0.01277991,0.002378127,0.00507941,0.02181002,0.08968305,0.1242056,0.002217037,0.2967371,0.001484167],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9719846,0.002890068,0.008004909,0.009668091,0.002955951,0.00160716,0.00008379293,0.00006062932,0.002744856],"genre_scores_gemma":[0.9398351,0.00007781513,0.05808229,0.0001826417,0.0008131459,0.000008639787,0.00001161927,0.00003197797,0.0009567433],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6634857,"threshold_uncertainty_score":0.9726315,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1098755632","doi":"10.1016/j.jcf.2016.04.001","title":"The benefits of newborn screening for cystic fibrosis: The Canadian experience","year":2016,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Montreal Children's Hospital; McGill University Health Centre; St. Michael's Hospital; Cystic Fibrosis Canada","funders":"","keywords":"Medicine; Cystic fibrosis; Incidence (geometry); Context (archaeology); Pediatrics; Newborn screening; Pseudomonas aeruginosa; Population; Internal medicine; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.02702242063517311,"gpt":0.3075695636971562,"spread":0.2805471430619831,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001296365,0.0002431527,0.0005416176,0.0002426075,0.0006212562,0.0001090415,0.000706361,0.0001080311,0.0000675369],"category_scores_gemma":[0.007844681,0.000107314,0.0003625751,0.0004209028,0.0006137842,0.0002902905,0.00007463934,0.00027524,0.00000861949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002964021,"about_ca_system_score_gemma":0.0009417119,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001993984,"about_ca_topic_score_gemma":0.005748314,"domain_scores_codex":[0.9967917,0.0001222091,0.001003047,0.0002283891,0.001097447,0.0007572562],"domain_scores_gemma":[0.9922717,0.004791617,0.0006509075,0.000571308,0.001139337,0.0005751699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.010646,0.0001780251,0.01109934,0.0006146961,0.0007817551,0.00005202535,0.002465935,0.0007709415,0.3264421,0.00308225,0.02470091,0.6191661],"study_design_scores_gemma":[0.01038344,0.009073339,0.3214571,0.01106919,0.001068997,0.001621515,0.003696071,0.00148187,0.08450702,0.003575244,0.551232,0.0008341144],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6993586,0.03933369,0.1980724,0.05399273,0.002671835,0.004298923,0.0009522224,0.00008476057,0.001234828],"genre_scores_gemma":[0.9334471,0.0001846029,0.06510092,0.0001384412,0.0005109317,0.00005595997,0.000002390045,0.00004454322,0.0005150876],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.618332,"threshold_uncertainty_score":0.9391383,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2586839394","doi":"10.1016/j.jcf.2017.01.007","title":"Effectiveness of a stepwise Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis","year":2017,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Cystic fibrosis; Regimen; Asymptomatic; Clearance; Pseudomonas aeruginosa; Tobramycin; Antibiotics; Internal medicine; Respiratory tract infections; Surgery; Retrospective cohort study; Pediatrics; Respiratory system; Gentamicin; Urology","retraction":null,"screen_n_in":null,"score":{"opus":0.01072974876980038,"gpt":0.3162022334722832,"spread":0.3054724847024828,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001606034,0.0003460007,0.001130217,0.0005917188,0.0001828371,0.00011735,0.000612425,0.0001488029,0.00006044447],"category_scores_gemma":[0.002906288,0.0002507384,0.0002492591,0.0003667549,0.0005199811,0.0006648551,0.0001201196,0.0004664732,0.00001050182],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003356416,"about_ca_system_score_gemma":0.0006568329,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001665923,"about_ca_topic_score_gemma":0.00001225072,"domain_scores_codex":[0.9963706,0.0003607192,0.001072531,0.0003698901,0.001326756,0.0004994769],"domain_scores_gemma":[0.9955289,0.0009330531,0.001544188,0.0009168193,0.0007139381,0.0003630986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02860788,0.001111343,0.5906239,0.003645841,0.000519704,0.0001280957,0.0001908882,0.0005444213,0.3664615,0.0001138658,0.0001837388,0.007868755],"study_design_scores_gemma":[0.01048144,0.004835792,0.9224581,0.006911195,0.0002681925,0.0009013513,0.00003633199,0.0002397132,0.05310841,0.0003370655,0.0001870377,0.0002354448],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9691897,0.0002345704,0.004623549,0.0002091443,0.00008058389,0.02535775,0.00004894822,0.00002075774,0.0002349735],"genre_scores_gemma":[0.9590599,0.00001122321,0.03708972,0.000008399556,0.000141571,0.003591323,0.000009501745,0.00005139602,0.00003698006],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3318341,"threshold_uncertainty_score":0.9999945,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2800214599","doi":"10.1016/j.jcf.2018.03.013","title":"The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF","year":2018,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto; Public Health Ontario; SickKids Foundation; Hospital for Sick Children","funders":"Sick Kids Foundation; Cystic Fibrosis Canada","keywords":"Medicine; Induced pluripotent stem cell; Nonsense mutation; Clinical trial; Genome editing; Cystic fibrosis; Bioinformatics; Missense mutation; Mutation; CRISPR; Internal medicine; Gene; Genetics; Embryonic stem cell; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.06318519408069662,"gpt":0.3987941557692554,"spread":0.3356089616885587,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004189644,0.0005929048,0.003004555,0.0005274285,0.0001761006,0.00005292455,0.001168232,0.0002164732,0.0000937141],"category_scores_gemma":[0.005221324,0.0002762359,0.0006367509,0.001185765,0.0009956817,0.00009624776,0.0001430953,0.001091989,0.000001273587],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00102153,"about_ca_system_score_gemma":0.004223939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006562883,"about_ca_topic_score_gemma":0.01713888,"domain_scores_codex":[0.9929685,0.000578827,0.002770479,0.000404114,0.002422693,0.0008553925],"domain_scores_gemma":[0.9878521,0.008463492,0.002059559,0.0007016803,0.0006282085,0.0002949521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002811091,0.0002572906,0.00004754759,0.008092691,0.000773657,0.00005336382,0.0005141083,0.000008572555,0.00002896786,0.0000768485,0.0148668,0.9724691],"study_design_scores_gemma":[0.004448325,0.004462182,0.0005195347,0.03684208,0.0008685423,0.0001936225,0.0007892892,0.00005120715,0.000009728208,0.00007140933,0.9515159,0.0002281715],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001361393,0.9916099,0.0002324687,0.003360141,0.0004167444,0.004024085,0.0001331211,0.000008600156,0.00007878258],"genre_scores_gemma":[0.0002276488,0.99272,0.004728854,0.0001276377,0.0009946798,0.0005459681,0.00004852646,0.00009490913,0.0005117409],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9722409,"threshold_uncertainty_score":0.999969,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2086926960","doi":"10.1016/j.jcf.2010.11.003","title":"Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF)","year":2010,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Microbiology; Streptococcus anginosus; Streptococcus mitis; Population; Penicillin; Biology; Medicine; Antibiotics; Streptococcus; Bacteria; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.005589534552872667,"gpt":0.2480214572630779,"spread":0.2424319227102053,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002162172,0.0004039986,0.0009496877,0.0004722925,0.0001638008,0.0001039003,0.0002278362,0.0002563176,0.0002049325],"category_scores_gemma":[0.000958095,0.0003042067,0.0001506112,0.0005389648,0.0001905171,0.0007956218,0.0001060097,0.0007978085,0.000002336651],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001368762,"about_ca_system_score_gemma":0.0001211998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001643985,"about_ca_topic_score_gemma":0.0001176597,"domain_scores_codex":[0.9966084,0.0001289041,0.001247552,0.000414652,0.001176374,0.0004241658],"domain_scores_gemma":[0.9960658,0.0005081103,0.001418114,0.0004244286,0.001178182,0.0004053492],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001950089,0.000152605,0.3504439,0.000231262,0.0001405874,0.00000948572,0.0002265735,0.00002849776,0.6413139,0.00001407844,0.00001249031,0.005476569],"study_design_scores_gemma":[0.004058841,0.00290274,0.966613,0.001455244,0.0004389602,0.00004050599,0.00008378844,0.001731443,0.02212302,0.0001722605,0.00009554231,0.0002846829],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936607,0.00006384379,0.004225142,0.0001116504,0.0003052166,0.0008447784,0.0007492112,0.00003242752,0.000006990871],"genre_scores_gemma":[0.9834495,0.00001809143,0.01555953,0.00002808255,0.0002725536,0.000009366118,0.0005827045,0.00006752404,0.00001262035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6191909,"threshold_uncertainty_score":0.999941,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}